Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT168 | Cell Line | P388 | Mus musculus | GI50 | 11.91 | nM | 16413779 | |
NPT755 | Individual Protein | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens | Potency | 31622.8 | nM | 17958396 | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 32.06 | nM | 19786608 | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 11.48 | nM | 3210015 | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 57.15 | nM | 9599262 | |
NPT1160 | Cell Line | BJ | Homo sapiens | EC50 | = | 7.18 | nM | 10425119 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 36.9 | nM | 7528786 | |
NPT1397 | Cell Line | INS1 | Rattus norvegicus | AC50 | = | 2132 | nM | 10.1016/S0960-894X(00)80319-4 |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 354.8 | nM | 8450319 |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 1629.3 | nM | 23891163 | |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 79432.8 | nM | 15620246 | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 112.2 | nM | 25730346 | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 18.11 | nM | 22365754 | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 10 | nM | 16441069 | |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 20 | nM | 17253840 |
NPT1283 | Individual Protein | Paired box protein Pax-8 | Homo sapiens | AC50 | < | 260 | nM | 20189404 |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 127.94 | nM | 14738383 | |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 228.56 | nM | 12350153 | |
NPT2 | Others | Unspecified | Potency | 1299.5 | nM | 18247573 | ||
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 39810.7 | nM | 16499327 |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 461.1 | nM | 18458131 | |
NPT2 | Others | Unspecified | Potency | 410.9 | nM | DrugMatrix in vitro pharmacology data | ||
NPT2 | Others | Unspecified | AC50 | = | 348 | nM | 10.1007/s00044-012-0026-x | |
NPT83 | Cell Line | MCF7 | Homo sapiens | ID50 | < | 3.2 | ug/ml | Open TG-GATES in vivo data: Hematology |
NPT2046 | Cell Line | EVSA-T | Homo sapiens | ID50 | < | 3.2 | ug/ml | Open TG-GATES in vivo data: Hematology |
NPT1183 | Cell Line | WiDr | Homo sapiens | ID50 | < | 3.2 | ug/ml | Open TG-GATES in vivo data: Hematology |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | ID50 | < | 3.2 | ug/ml | Open TG-GATES in vivo data: Hematology |
NPT573 | Cell Line | M19-MEL | Homo sapiens | ID50 | < | 24 | ug/ml | Open TG-GATES in vivo data: Hematology |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 651.3 | nM | Open TG-GATES in vivo data: Biochemistry | |
NPT2 | Others | Unspecified | AC50 | < | 260 | nM | DrugMatrix in vivo data: Pathology | |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 17782.8 | nM | 8277308 |
NPT2 | Others | Unspecified | IC50 | = | 6020 | nM | PubChem BioAssay data set | |
NPT1797 | Individual Protein | Alpha trans-inducing protein (VP16) | Herpes simplex virus (type 1 / strain 17) | IC50 | 1991 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 10.21 | nM | 20359898 | |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 1409.2 | nM | DrugMatrix in vitro pharmacology data |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 18.79 | nM | PubChem BioAssay data set | |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | 64.27 | nM | 9599253 | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 12.79 | nM | 24707938 | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 10 | nM | PubChem BioAssay data set | |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 39810.7 | nM | 1710654 |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 17782.8 | nM | 18053715 | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 196.79 | nM | 19115838 | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 272.27 | nM | 15974630 | |
NPT2 | Others | Unspecified | IC50 | = | 8.5 | nM | 19700322 | |
NPT2 | Others | Unspecified | AC50 | = | 2470 | nM | 20155932 | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 103.51 | nM | 10924160 | |
NPT2 | Others | Unspecified | IC50 | = | 620 | nM | 16378377 | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 156.68 | nM | 26222693 | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 177.01 | nM | 23747224 | |
NPT58 | Individual Protein | Bloom syndrome protein | Homo sapiens | Potency | = | 28183.8 | nM | 22264149 |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 4216.97 | nM | 18211005 | |
NPT2 | Others | Unspecified | IC50 | > | 80000 | nM | PubChem BioAssay data set | |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 562.3 | nM | 23294699 | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 10 | nM | 11374942 | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 11.78 | nM | PubChem BioAssay data set | |
NPT536 | Uncleic Acid | microRNA 21 | Homo sapiens | Potency | = | 1309.2 | nM | 10.6019/CHEMBL1201861 |
NPT578 | Cell Line | SNB-78 | Homo sapiens | GI50 | 574.12 | nM | 19348465 | |
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | 112.2 | nM | 19769341 | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 110.66 | nM | 26331426 | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 118.03 | nM | 15482934 | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 340.41 | nM | 19459643 | |
NPT2 | Others | Unspecified | EC50 | > | 350000 | nM | 17470649 | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 40.83 | nM | 19371978 | |
NPT4462 | Cell Line | NCI-H928 | IC50 | = | 7.9 | nM | 18955526 | |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | = | 3.5 | nM | 18955526 |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 10 | nM | 19651906 | |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | 19.82 | nM | 19651915 | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 10.76 | nM | 20585130 | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 68.39 | nM | 19506058 | |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 1158.2 | nM | 21078949 | |
NPT143 | Individual Protein | DNA topoisomerase I | Homo sapiens | IC50 | = | 110 | nM | DrugMatrix in vitro pharmacology data |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 10.21 | nM | 10.1007/s00044-011-9964-y | |
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | 22387.2 | nM | 10.1007/s00044-013-0484-9 | |
NPT35 | Others | n.a. | AC50 | < | 260 | nM | 10.1039/C4MD00399C | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | IC50 | = | 6.6 | nM | 11473430 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 7.4 | nM | 19132934 |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 207.01 | nM | 19318257 | |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 25118.9 | nM | 25466192 |
NPT537 | Individual Protein | Ras-related protein Rab-9A | Homo sapiens | Potency | = | 2238.7 | nM | 22264149 |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 58 | nM | 25397992 | |
NPT732 | Cell Line | HOP-18 | Homo sapiens | GI50 | 27.73 | nM | 26295595 | |
NPT143 | Individual Protein | DNA topoisomerase I | Homo sapiens | Activity | = | 87 | % | 10924160 |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 10 | nM | 23434030 | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 10 | nM | 23360104 | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 10 | nM | 22305342 | |
NPT59 | Individual Protein | DNA polymerase beta | Homo sapiens | Potency | = | 50118.7 | nM | 11741487 |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 79.43 | nM | PubChem BioAssay data set | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 15.7 | nM | PubChem BioAssay data set | |
NPT536 | Uncleic Acid | microRNA 21 | Homo sapiens | Potency | = | 1309.2 | nM | 9677284 |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 215.28 | nM | 12762820 | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 10 | nM | 3443856 | |
NPT2 | Others | Unspecified | AC50 | = | 463 | nM | 10377219 | |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 12.7 | nM | 21216051 |
NPT143 | Individual Protein | DNA topoisomerase I | Homo sapiens | IC50 | = | 4200 | nM | 21216051 |
NPT2 | Others | Unspecified | EC50 | > | 350000 | nM | 22582991 | |
NPT731 | Cell Line | LXFL 529 | Homo sapiens | GI50 | 243.78 | nM | 23550966 | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 72.78 | nM | 10.6019/CHEMBL1201861 | |
NPT1415 | Individual Protein | Heat shock factor protein 1 | Mus musculus | EC50 | > | 260000 | nM | Open TG-GATES in vivo data: Pathology |
NPT2 | Others | Unspecified | Potency | 163.6 | nM | 25700232 | ||
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 1852.6 | nM | 19754130 | |
NPT105 | Individual Protein | Muscleblind-like protein 1 | Homo sapiens | Potency | 8912.5 | nM | 11277756 | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 246.04 | nM | 12398531 | |
NPT2 | Others | Unspecified | Potency | 10000 | nM | 24689881 | ||
NPT738 | Cell Line | SN12K1 | Homo sapiens | GI50 | 22.7 | nM | 26042639 | |
NPT2 | Others | Unspecified | IC50 | < | 160 | nM | 23691952 | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 10 | nM | 20151678 | |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 35481.3 | nM | 24571273 | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 237.68 | nM | 10869210 | |
NPT1798 | Individual Protein | Photoreceptor-specific nuclear receptor | Homo sapiens | IC50 | 895.89 | nM | 11374943 | |
NPT2 | Others | Unspecified | Potency | 130 | nM | 18512987 | ||
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | 143.22 | nM | 19949061 | |
NPT2 | Others | Unspecified | Potency | 1299.5 | nM | 23586757 | ||
NPT552 | Cell Line | P388/ADR | Mus musculus | GI50 | 17.38 | nM | 23398362 | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 10 | nM | 16309309 | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 10 | nM | 23621813 | |
NPT2 | Others | Unspecified | Potency | 1000 | nM | 25740159 | ||
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 230.14 | nM | 19835393 | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 27.23 | nM | 19132934 | |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 35481.3 | nM | 23354070 | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 79432.8 | nM | 18975929 | |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 2059.6 | nM | 18336005 | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 76.38 | nM | 21643465 | |
NPT156 | Individual Protein | Sphingomyelin phosphodiesterase | Homo sapiens | Potency | 15848.9 | nM | 12662097 | |
NPT576 | Cell Line | DMS-114 | Homo sapiens | GI50 | 10 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 1000 | nM | 17938184 | ||
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | 10 | nM | 19258280 | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 14.83 | nM | DrugMatrix in vitro pharmacology data | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 10 | nM | 17461599 | |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 12 | nM | 12444684 |
NPT577 | Cell Line | RXF 631 | Homo sapiens | GI50 | 37.5 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 10 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 17.5 | nM | 25647077 | |
NPT11 | Individual Protein | Guanine nucleotide-binding protein G(s), subunit alpha | Homo sapiens | Potency | 15848.9 | nM | 15387649 | |
NPT376 | Cell Line | A498 | Homo sapiens | ID50 | < | 10 | ug/ml | DrugMatrix in vitro pharmacology data |
NPT535 | Individual Protein | Parathyroid hormone receptor | Homo sapiens | Potency | 44668.4 | nM | 17850214 | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | ID50 | < | 7 | ug/ml | 15711537 |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | 566.24 | nM | 18183025 | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 259.3 | nM | 22037378 | |
NPT143 | Individual Protein | DNA topoisomerase I | Homo sapiens | CC50 | = | 900 | nM | PubChem BioAssay data set |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 63.24 | nM | 17158054 | |
NPT2 | Others | Unspecified | Potency | 920 | nM | PubChem BioAssay data set | ||
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 35.65 | nM | 15646539 | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 11.32 | nM | 12852764 | |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 5011.9 | nM | 17850214 | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 2059.6 | nM | 2342057 | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 10 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 232.81 | nM | 19687244 | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 10 | nM | 25443644 | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 1168.9 | nM | 17958397 | |
NPT143 | Individual Protein | DNA topoisomerase I | Homo sapiens | IC50 | = | 1800 | nM | 12027764 |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 12.7 | nM | 12027764 |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 10 | nM | 16643022 | |
NPT2 | Others | Unspecified | Potency | 1258.9 | nM | 19419201 | ||
NPT3 | Individual Protein | Thioredoxin glutathione reductase | Schistosoma mansoni | Potency | = | 50118.7 | nM | 26316467 |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 78.52 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 10 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC192674 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9602 | High Similarity | NPC129909 |
0.927 | High Similarity | NPC61435 |
0.9266 | High Similarity | NPC311858 |
0.9153 | High Similarity | NPC470003 |
0.887 | High Similarity | NPC28848 |
0.887 | High Similarity | NPC14325 |
0.8622 | High Similarity | NPC151781 |
0.8622 | High Similarity | NPC74562 |
0.8622 | High Similarity | NPC316181 |
0.8366 | Intermediate Similarity | NPC128115 |
0.8325 | Intermediate Similarity | NPC477548 |
0.7594 | Intermediate Similarity | NPC65080 |
0.75 | Intermediate Similarity | NPC24864 |
0.745 | Intermediate Similarity | NPC245916 |
0.7427 | Intermediate Similarity | NPC474905 |
0.7366 | Intermediate Similarity | NPC476115 |
0.734 | Intermediate Similarity | NPC241024 |
0.7323 | Intermediate Similarity | NPC175474 |
0.7317 | Intermediate Similarity | NPC123019 |
0.7313 | Intermediate Similarity | NPC19692 |
0.7313 | Intermediate Similarity | NPC220151 |
0.7302 | Intermediate Similarity | NPC470509 |
0.73 | Intermediate Similarity | NPC55493 |
0.7295 | Intermediate Similarity | NPC277350 |
0.7283 | Intermediate Similarity | NPC281094 |
0.7268 | Intermediate Similarity | NPC471944 |
0.7243 | Intermediate Similarity | NPC471458 |
0.7243 | Intermediate Similarity | NPC82070 |
0.7238 | Intermediate Similarity | NPC470440 |
0.7236 | Intermediate Similarity | NPC111602 |
0.7236 | Intermediate Similarity | NPC196251 |
0.7236 | Intermediate Similarity | NPC102338 |
0.7236 | Intermediate Similarity | NPC63199 |
0.7228 | Intermediate Similarity | NPC289299 |
0.7228 | Intermediate Similarity | NPC57994 |
0.722 | Intermediate Similarity | NPC254240 |
0.722 | Intermediate Similarity | NPC312870 |
0.722 | Intermediate Similarity | NPC128265 |
0.722 | Intermediate Similarity | NPC199851 |
0.722 | Intermediate Similarity | NPC294909 |
0.7209 | Intermediate Similarity | NPC52254 |
0.7207 | Intermediate Similarity | NPC238499 |
0.7206 | Intermediate Similarity | NPC212213 |
0.7206 | Intermediate Similarity | NPC239954 |
0.7206 | Intermediate Similarity | NPC52557 |
0.7172 | Intermediate Similarity | NPC280290 |
0.717 | Intermediate Similarity | NPC235900 |
0.7166 | Intermediate Similarity | NPC299594 |
0.7163 | Intermediate Similarity | NPC174788 |
0.715 | Intermediate Similarity | NPC476114 |
0.7143 | Intermediate Similarity | NPC91179 |
0.7136 | Intermediate Similarity | NPC249150 |
0.7136 | Intermediate Similarity | NPC81654 |
0.7136 | Intermediate Similarity | NPC49196 |
0.7136 | Intermediate Similarity | NPC79129 |
0.7136 | Intermediate Similarity | NPC195461 |
0.7136 | Intermediate Similarity | NPC313985 |
0.7129 | Intermediate Similarity | NPC472113 |
0.7128 | Intermediate Similarity | NPC326575 |
0.7122 | Intermediate Similarity | NPC168911 |
0.7108 | Intermediate Similarity | NPC102592 |
0.7108 | Intermediate Similarity | NPC79356 |
0.7105 | Intermediate Similarity | NPC8104 |
0.7103 | Intermediate Similarity | NPC471284 |
0.7103 | Intermediate Similarity | NPC477979 |
0.71 | Intermediate Similarity | NPC472323 |
0.7098 | Intermediate Similarity | NPC470498 |
0.7092 | Intermediate Similarity | NPC270009 |
0.709 | Intermediate Similarity | NPC473320 |
0.7087 | Intermediate Similarity | NPC32200 |
0.708 | Intermediate Similarity | NPC470785 |
0.708 | Intermediate Similarity | NPC470784 |
0.7078 | Intermediate Similarity | NPC475271 |
0.7071 | Intermediate Similarity | NPC472108 |
0.7071 | Intermediate Similarity | NPC139291 |
0.7071 | Intermediate Similarity | NPC472110 |
0.7071 | Intermediate Similarity | NPC472109 |
0.7065 | Intermediate Similarity | NPC46413 |
0.7062 | Intermediate Similarity | NPC161861 |
0.7059 | Intermediate Similarity | NPC470507 |
0.7053 | Intermediate Similarity | NPC470497 |
0.7053 | Intermediate Similarity | NPC214428 |
0.705 | Intermediate Similarity | NPC66210 |
0.7039 | Intermediate Similarity | NPC50503 |
0.7039 | Intermediate Similarity | NPC470499 |
0.7037 | Intermediate Similarity | NPC96131 |
0.7037 | Intermediate Similarity | NPC312645 |
0.7035 | Intermediate Similarity | NPC228835 |
0.7035 | Intermediate Similarity | NPC21429 |
0.7035 | Intermediate Similarity | NPC184680 |
0.703 | Intermediate Similarity | NPC472112 |
0.703 | Intermediate Similarity | NPC314333 |
0.7027 | Intermediate Similarity | NPC37548 |
0.7016 | Intermediate Similarity | NPC271734 |
0.7016 | Intermediate Similarity | NPC478184 |
0.7016 | Intermediate Similarity | NPC478182 |
0.7011 | Intermediate Similarity | NPC478186 |
0.701 | Intermediate Similarity | NPC198673 |
0.7005 | Intermediate Similarity | NPC11126 |
0.7005 | Intermediate Similarity | NPC12649 |
0.7 | Intermediate Similarity | NPC472107 |
0.7 | Intermediate Similarity | NPC133003 |
0.7 | Intermediate Similarity | NPC79062 |
0.699 | Remote Similarity | NPC472122 |
0.699 | Remote Similarity | NPC24594 |
0.6985 | Remote Similarity | NPC472444 |
0.6985 | Remote Similarity | NPC472104 |
0.6985 | Remote Similarity | NPC469358 |
0.6978 | Remote Similarity | NPC277157 |
0.6977 | Remote Similarity | NPC317752 |
0.6974 | Remote Similarity | NPC472123 |
0.697 | Remote Similarity | NPC15840 |
0.6965 | Remote Similarity | NPC135601 |
0.6965 | Remote Similarity | NPC478077 |
0.6965 | Remote Similarity | NPC141612 |
0.6965 | Remote Similarity | NPC17273 |
0.6963 | Remote Similarity | NPC194881 |
0.6955 | Remote Similarity | NPC155444 |
0.695 | Remote Similarity | NPC472119 |
0.695 | Remote Similarity | NPC258480 |
0.6938 | Remote Similarity | NPC300183 |
0.6933 | Remote Similarity | NPC89987 |
0.693 | Remote Similarity | NPC318299 |
0.6927 | Remote Similarity | NPC271797 |
0.6927 | Remote Similarity | NPC21174 |
0.6923 | Remote Similarity | NPC14812 |
0.6923 | Remote Similarity | NPC6982 |
0.6919 | Remote Similarity | NPC133261 |
0.6919 | Remote Similarity | NPC472443 |
0.6912 | Remote Similarity | NPC472097 |
0.6909 | Remote Similarity | NPC2395 |
0.6908 | Remote Similarity | NPC469736 |
0.6907 | Remote Similarity | NPC472435 |
0.6907 | Remote Similarity | NPC317430 |
0.6905 | Remote Similarity | NPC162730 |
0.6903 | Remote Similarity | NPC323752 |
0.6903 | Remote Similarity | NPC323198 |
0.6902 | Remote Similarity | NPC242556 |
0.69 | Remote Similarity | NPC470205 |
0.6898 | Remote Similarity | NPC89508 |
0.6897 | Remote Similarity | NPC34271 |
0.6888 | Remote Similarity | NPC34508 |
0.6884 | Remote Similarity | NPC472105 |
0.6884 | Remote Similarity | NPC187827 |
0.6878 | Remote Similarity | NPC478141 |
0.6878 | Remote Similarity | NPC38736 |
0.6869 | Remote Similarity | NPC478158 |
0.6866 | Remote Similarity | NPC478157 |
0.6864 | Remote Similarity | NPC61813 |
0.6864 | Remote Similarity | NPC472099 |
0.6863 | Remote Similarity | NPC329858 |
0.6863 | Remote Similarity | NPC469501 |
0.6863 | Remote Similarity | NPC469470 |
0.6859 | Remote Similarity | NPC293487 |
0.6857 | Remote Similarity | NPC475506 |
0.6856 | Remote Similarity | NPC474183 |
0.6853 | Remote Similarity | NPC189812 |
0.6853 | Remote Similarity | NPC469938 |
0.6853 | Remote Similarity | NPC329688 |
0.6852 | Remote Similarity | NPC475778 |
0.685 | Remote Similarity | NPC113626 |
0.6849 | Remote Similarity | NPC281049 |
0.6847 | Remote Similarity | NPC17059 |
0.6845 | Remote Similarity | NPC187951 |
0.6842 | Remote Similarity | NPC272549 |
0.6837 | Remote Similarity | NPC234999 |
0.6835 | Remote Similarity | NPC152768 |
0.6835 | Remote Similarity | NPC148183 |
0.6834 | Remote Similarity | NPC219336 |
0.683 | Remote Similarity | NPC476491 |
0.6829 | Remote Similarity | NPC473763 |
0.6829 | Remote Similarity | NPC243716 |
0.6829 | Remote Similarity | NPC117244 |
0.6825 | Remote Similarity | NPC295898 |
0.6825 | Remote Similarity | NPC474116 |
0.6825 | Remote Similarity | NPC155143 |
0.682 | Remote Similarity | NPC234078 |
0.682 | Remote Similarity | NPC472436 |
0.682 | Remote Similarity | NPC221100 |
0.6816 | Remote Similarity | NPC235885 |
0.6816 | Remote Similarity | NPC143533 |
0.6814 | Remote Similarity | NPC14288 |
0.6812 | Remote Similarity | NPC474121 |
0.6812 | Remote Similarity | NPC294693 |
0.6808 | Remote Similarity | NPC238457 |
0.6808 | Remote Similarity | NPC18661 |
0.6808 | Remote Similarity | NPC317373 |
0.6806 | Remote Similarity | NPC250129 |
0.6802 | Remote Similarity | NPC220851 |
0.68 | Remote Similarity | NPC191382 |
0.68 | Remote Similarity | NPC56109 |
0.68 | Remote Similarity | NPC469896 |
0.6798 | Remote Similarity | NPC94752 |
0.6796 | Remote Similarity | NPC472292 |
0.6794 | Remote Similarity | NPC102008 |
0.6794 | Remote Similarity | NPC473640 |
0.6794 | Remote Similarity | NPC149708 |
0.6794 | Remote Similarity | NPC474916 |
0.6791 | Remote Similarity | NPC284102 |
0.6787 | Remote Similarity | NPC272174 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC192674 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD3800 | Clinical (unspecified phase) |
0.9602 | High Similarity | NPD3785 | Clinical (unspecified phase) |
0.9556 | High Similarity | NPD6248 | Phase 2 |
0.9556 | High Similarity | NPD6249 | Phase 2 |
0.9348 | High Similarity | NPD5487 | Phase 1 |
0.9348 | High Similarity | NPD3777 | Phase 3 |
0.9337 | High Similarity | NPD6206 | Phase 1 |
0.9286 | High Similarity | NPD6261 | Phase 3 |
0.9266 | High Similarity | NPD5444 | Phase 1 |
0.9081 | High Similarity | NPD5427 | Suspended |
0.895 | High Similarity | NPD4334 | Discontinued |
0.8942 | High Similarity | NPD4901 | Clinical (unspecified phase) |
0.8802 | High Similarity | NPD5834 | Phase 3 |
0.8802 | High Similarity | NPD5835 | Phase 3 |
0.8763 | High Similarity | NPD7573 | Discontinued |
0.8703 | High Similarity | NPD4315 | Phase 2 |
0.8579 | High Similarity | NPD4897 | Phase 2 |
0.8469 | Intermediate Similarity | NPD4900 | Clinical (unspecified phase) |
0.8325 | Intermediate Similarity | NPD5507 | Approved |
0.8325 | Intermediate Similarity | NPD5506 | Approved |
0.8221 | Intermediate Similarity | NPD7589 | Clinical (unspecified phase) |
0.7972 | Intermediate Similarity | NPD7797 | Approved |
0.7972 | Intermediate Similarity | NPD7796 | Approved |
0.7902 | Intermediate Similarity | NPD7218 | Clinical (unspecified phase) |
0.7622 | Intermediate Similarity | NPD2915 | Discontinued |
0.7619 | Intermediate Similarity | NPD5104 | Approved |
0.7617 | Intermediate Similarity | NPD5075 | Discontinued |
0.7591 | Intermediate Similarity | NPD7025 | Clinical (unspecified phase) |
0.7263 | Intermediate Similarity | NPD5020 | Approved |
0.7228 | Intermediate Similarity | NPD4602 | Approved |
0.722 | Intermediate Similarity | NPD4500 | Approved |
0.722 | Intermediate Similarity | NPD4501 | Approved |
0.7217 | Intermediate Similarity | NPD3794 | Approved |
0.7217 | Intermediate Similarity | NPD3795 | Approved |
0.72 | Intermediate Similarity | NPD3321 | Discontinued |
0.7186 | Intermediate Similarity | NPD3390 | Phase 2 |
0.7172 | Intermediate Similarity | NPD4336 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD5897 | Approved |
0.7143 | Intermediate Similarity | NPD5899 | Approved |
0.7143 | Intermediate Similarity | NPD5898 | Approved |
0.7136 | Intermediate Similarity | NPD4601 | Approved |
0.7136 | Intermediate Similarity | NPD4600 | Approved |
0.7115 | Intermediate Similarity | NPD6176 | Phase 1 |
0.7101 | Intermediate Similarity | NPD7727 | Phase 2 |
0.7098 | Intermediate Similarity | NPD6739 | Clinical (unspecified phase) |
0.7079 | Intermediate Similarity | NPD5592 | Clinical (unspecified phase) |
0.7073 | Intermediate Similarity | NPD5003 | Discontinued |
0.7043 | Intermediate Similarity | NPD2882 | Phase 1 |
0.7042 | Intermediate Similarity | NPD6567 | Clinical (unspecified phase) |
0.7039 | Intermediate Similarity | NPD4987 | Clinical (unspecified phase) |
0.7035 | Intermediate Similarity | NPD7482 | Phase 2 |
0.7035 | Intermediate Similarity | NPD7483 | Phase 2 |
0.703 | Intermediate Similarity | NPD4499 | Approved |
0.7023 | Intermediate Similarity | NPD5293 | Phase 2 |
0.7019 | Intermediate Similarity | NPD7903 | Clinical (unspecified phase) |
0.7015 | Intermediate Similarity | NPD6141 | Clinical (unspecified phase) |
0.698 | Remote Similarity | NPD6965 | Clinical (unspecified phase) |
0.6965 | Remote Similarity | NPD5809 | Phase 3 |
0.6963 | Remote Similarity | NPD5475 | Discontinued |
0.6961 | Remote Similarity | NPD5505 | Discontinued |
0.6955 | Remote Similarity | NPD6824 | Clinical (unspecified phase) |
0.6941 | Remote Similarity | NPD3280 | Approved |
0.6938 | Remote Similarity | NPD7817 | Phase 1 |
0.6934 | Remote Similarity | NPD6838 | Clinical (unspecified phase) |
0.6927 | Remote Similarity | NPD7878 | Phase 2 |
0.6923 | Remote Similarity | NPD7716 | Approved |
0.6923 | Remote Similarity | NPD7717 | Approved |
0.6919 | Remote Similarity | NPD7712 | Clinical (unspecified phase) |
0.6919 | Remote Similarity | NPD8114 | Approved |
0.6919 | Remote Similarity | NPD8115 | Approved |
0.6915 | Remote Similarity | NPD5555 | Phase 1 |
0.6901 | Remote Similarity | NPD2509 | Approved |
0.6901 | Remote Similarity | NPD2510 | Approved |
0.69 | Remote Similarity | NPD5596 | Phase 2 |
0.6895 | Remote Similarity | NPD4326 | Phase 2 |
0.6888 | Remote Similarity | NPD6182 | Approved |
0.6888 | Remote Similarity | NPD43 | Approved |
0.6888 | Remote Similarity | NPD6183 | Clinical (unspecified phase) |
0.6887 | Remote Similarity | NPD6732 | Clinical (unspecified phase) |
0.6881 | Remote Similarity | NPD8327 | Clinical (unspecified phase) |
0.6881 | Remote Similarity | NPD8325 | Phase 3 |
0.6881 | Remote Similarity | NPD8326 | Phase 3 |
0.6872 | Remote Similarity | NPD2121 | Clinical (unspecified phase) |
0.6863 | Remote Similarity | NPD2564 | Approved |
0.6863 | Remote Similarity | NPD2565 | Phase 2 |
0.6861 | Remote Similarity | NPD8289 | Discontinued |
0.6858 | Remote Similarity | NPD6263 | Clinical (unspecified phase) |
0.6852 | Remote Similarity | NPD7594 | Clinical (unspecified phase) |
0.6848 | Remote Similarity | NPD4637 | Clinical (unspecified phase) |
0.684 | Remote Similarity | NPD3947 | Discontinued |
0.6825 | Remote Similarity | NPD5721 | Clinical (unspecified phase) |
0.6814 | Remote Similarity | NPD8372 | Clinical (unspecified phase) |
0.6812 | Remote Similarity | NPD7619 | Phase 3 |
0.6812 | Remote Similarity | NPD7618 | Phase 3 |
0.681 | Remote Similarity | NPD6479 | Discontinued |
0.6809 | Remote Similarity | NPD4463 | Approved |
0.6809 | Remote Similarity | NPD4462 | Approved |
0.6806 | Remote Similarity | NPD7070 | Clinical (unspecified phase) |
0.6806 | Remote Similarity | NPD7470 | Discontinued |
0.6804 | Remote Similarity | NPD5744 | Clinical (unspecified phase) |
0.6804 | Remote Similarity | NPD7823 | Clinical (unspecified phase) |
0.68 | Remote Similarity | NPD7780 | Approved |
0.68 | Remote Similarity | NPD7781 | Approved |
0.6798 | Remote Similarity | NPD7026 | Phase 2 |
0.6794 | Remote Similarity | NPD53 | Approved |
0.6794 | Remote Similarity | NPD7778 | Approved |
0.6794 | Remote Similarity | NPD7777 | Approved |
0.6791 | Remote Similarity | NPD4520 | Approved |
0.6789 | Remote Similarity | NPD6285 | Phase 2 |
0.6779 | Remote Similarity | NPD7061 | Clinical (unspecified phase) |
0.6769 | Remote Similarity | NPD4554 | Clinical (unspecified phase) |
0.6768 | Remote Similarity | NPD5065 | Approved |
0.6766 | Remote Similarity | NPD4204 | Approved |
0.6766 | Remote Similarity | NPD4203 | Approved |
0.6765 | Remote Similarity | NPD3961 | Discontinued |
0.6765 | Remote Similarity | NPD4948 | Discontinued |
0.6762 | Remote Similarity | NPD7621 | Clinical (unspecified phase) |
0.6762 | Remote Similarity | NPD7308 | Discontinued |
0.6758 | Remote Similarity | NPD3394 | Approved |
0.6758 | Remote Similarity | NPD3393 | Approved |
0.6758 | Remote Similarity | NPD3389 | Approved |
0.6756 | Remote Similarity | NPD6292 | Clinical (unspecified phase) |
0.6754 | Remote Similarity | NPD6396 | Clinical (unspecified phase) |
0.6754 | Remote Similarity | NPD6395 | Phase 2 |
0.6754 | Remote Similarity | NPD4373 | Phase 2 |
0.675 | Remote Similarity | NPD4079 | Approved |
0.675 | Remote Similarity | NPD3077 | Approved |
0.675 | Remote Similarity | NPD3079 | Approved |
0.675 | Remote Similarity | NPD3078 | Approved |
0.675 | Remote Similarity | NPD4076 | Approved |
0.675 | Remote Similarity | NPD3076 | Approved |
0.6748 | Remote Similarity | NPD6630 | Clinical (unspecified phase) |
0.6744 | Remote Similarity | NPD7947 | Clinical (unspecified phase) |
0.6742 | Remote Similarity | NPD7404 | Approved |
0.6735 | Remote Similarity | NPD4640 | Approved |
0.6735 | Remote Similarity | NPD4638 | Approved |
0.6735 | Remote Similarity | NPD4639 | Approved |
0.6734 | Remote Similarity | NPD4075 | Phase 2 |
0.6734 | Remote Similarity | NPD5501 | Discontinued |
0.6733 | Remote Similarity | NPD5728 | Clinical (unspecified phase) |
0.6731 | Remote Similarity | NPD7944 | Discontinued |
0.6716 | Remote Similarity | NPD6878 | Phase 2 |
0.6716 | Remote Similarity | NPD2591 | Phase 2 |
0.6716 | Remote Similarity | NPD6452 | Discontinued |
0.6716 | Remote Similarity | NPD5473 | Discontinued |
0.6716 | Remote Similarity | NPD6879 | Phase 2 |
0.6715 | Remote Similarity | NPD4950 | Approved |
0.6703 | Remote Similarity | NPD1256 | Approved |
0.6703 | Remote Similarity | NPD1255 | Approved |
0.6703 | Remote Similarity | NPD1254 | Approved |
0.6703 | Remote Similarity | NPD1253 | Approved |
0.6701 | Remote Similarity | NPD2480 | Clinical (unspecified phase) |
0.67 | Remote Similarity | NPD3505 | Approved |
0.67 | Remote Similarity | NPD3506 | Approved |
0.6699 | Remote Similarity | NPD6281 | Approved |
0.6699 | Remote Similarity | NPD6449 | Clinical (unspecified phase) |
0.6696 | Remote Similarity | NPD7548 | Discontinued |
0.6685 | Remote Similarity | NPD3385 | Approved |
0.6684 | Remote Similarity | NPD6158 | Phase 2 |
0.6684 | Remote Similarity | NPD6476 | Clinical (unspecified phase) |
0.6683 | Remote Similarity | NPD1783 | Clinical (unspecified phase) |
0.6683 | Remote Similarity | NPD6492 | Phase 2 |
0.6683 | Remote Similarity | NPD4399 | Phase 2 |
0.6682 | Remote Similarity | NPD5901 | Discontinued |
0.6667 | Remote Similarity | NPD6227 | Discontinued |
0.6667 | Remote Similarity | NPD2590 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD7666 | Phase 3 |
0.6667 | Remote Similarity | NPD5088 | Discontinued |
0.6667 | Remote Similarity | NPD5140 | Approved |
0.6667 | Remote Similarity | NPD7665 | Phase 2 |
0.6667 | Remote Similarity | NPD7424 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD7271 | Approved |
0.6667 | Remote Similarity | NPD5138 | Approved |
0.6667 | Remote Similarity | NPD6247 | Clinical (unspecified phase) |
0.6652 | Remote Similarity | NPD6995 | Phase 1 |
0.6652 | Remote Similarity | NPD6209 | Approved |
0.6652 | Remote Similarity | NPD8406 | Clinical (unspecified phase) |
0.6651 | Remote Similarity | NPD6220 | Phase 3 |
0.6651 | Remote Similarity | NPD7001 | Phase 3 |
0.6649 | Remote Similarity | NPD2511 | Approved |
0.6637 | Remote Similarity | NPD5850 | Phase 3 |
0.6636 | Remote Similarity | NPD4506 | Discontinued |
0.6636 | Remote Similarity | NPD6529 | Discontinued |
0.6635 | Remote Similarity | NPD4376 | Phase 3 |
0.6633 | Remote Similarity | NPD750 | Phase 2 |
0.6633 | Remote Similarity | NPD4550 | Clinical (unspecified phase) |
0.6632 | Remote Similarity | NPD4671 | Clinical (unspecified phase) |
0.6632 | Remote Similarity | NPD4669 | Clinical (unspecified phase) |
0.6632 | Remote Similarity | NPD4670 | Clinical (unspecified phase) |
0.6624 | Remote Similarity | NPD6716 | Phase 1 |
0.6623 | Remote Similarity | NPD4952 | Phase 3 |
0.6622 | Remote Similarity | NPD6173 | Approved |
0.6621 | Remote Similarity | NPD6657 | Clinical (unspecified phase) |
0.662 | Remote Similarity | NPD8322 | Phase 2 |
0.6618 | Remote Similarity | NPD7564 | Discontinued |
0.6617 | Remote Similarity | NPD6641 | Approved |
0.6617 | Remote Similarity | NPD6642 | Approved |
0.6613 | Remote Similarity | NPD6301 | Phase 2 |
0.6608 | Remote Similarity | NPD7730 | Approved |
0.6608 | Remote Similarity | NPD7731 | Approved |
PubChem CID   | 72402 |
ChEMBL   | CHEMBL274070 |
ZINC   |
Molecular Weight:   | 363.12 |
ALogP:   | -2.3369 |
MLogP:   | 2.89 |
XLogP:   | 0.892 |
# Rotatable Bonds:   | 4 |
Polar Surface Area:   | 105.75 |
# H-Bond Aceptor:   | 7 |
# H-Bond Donor:   | 2 |
# Rings:   | 5 |
# Heavy Atoms:   | 27 |